`Patent 7,772,209
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`WOCKHARDT BIO AG,
`Petitioner,
`
`v.
`
`ELI LILLY & COMPANY,
`Patent Owner.
`__________________
`
`Case No: IPR2016-01393
`Patent No. 7,772,209
`__________________
`
`
`
`
`
`
`
`PATENT OWNER ELI LILLY & COMPANY’S MANDATORY NOTICES
`UNDER 37 C.F.R. § 42.8(a)(2)
`
`Patent Owner Eli Lilly and Company hereby files mandatory notices
`
`pursuant to 37 C.F.R. § 42.8(a)(2). These notices are being timely filed within 21
`
`days of the service of the Petition. The Petition was filed on July 8, 2016.
`
`
`
`A. Real Party-In-Interest (37 C.F.R. § 42.8(b)(1))
`Eli Lilly and Company is the owner of the entire interest in U.S. Patent No.
`
`Case IPR 2016-01393
`Patent 7,772,209
`
`7,772,209.
`
`B. Notice of Related Matters (37 C.F.R. § 42.8(b)(2)).
`The Patent Owner identifies the following copending litigation that may
`
`affect, or may be affected by, a decision in this Inter Partes Review:
`
` Eli Lilly & Co. v. Teva Parenteral Medicines Inc., APP Pharms., LLC,
`
`Pliva Hrvatska d.o.o., Teva Pharms. USA, Inc., and Barr Labs., Inc.,
`
`Federal Circuit Case No. 2015-2067 (appealed from S.D. Indiana
`
`Case No. 1:10-cv-1376-TWP-DKL)
`
` Eli Lilly & Co. v. Accord Healthcare Inc. and Apotex Inc., S.D.
`
`Indiana Case No. 1:12-cv-0086-TWP-DKL
`
` Eli Lilly & Co. v. Sun Pharm. Indus. Ltd. and Sun Pharma Global
`
`FZE, S.D. Indiana Case No. 1:13-cv-1469-TWP-DKL
`
` Eli Lilly & Co. v. Glenmark Generics, Inc., USA, S.D. Indiana Case
`
`No. 1:14-0104-TWP-DKL
`
` Eli Lilly & Co. and the Trustees of Princeton Univ. v. Nang Kuang
`
`Pharm. Co., Ltd., CANDA NK-2, LLC, Sandoz Inc., Mylan Labs. Ltd.,
`
`Mylan Inc., Emcure Pharms. Ltd., Heritage Pharma Labs Inc., and
`
`
`
`2
`
`
`
`Case IPR 2016-01393
`Patent 7,772,209
`Heritage Pharms., Inc., S.D. Indiana Case No. 1:14-cv-1647-TWP-
`
`DKL (consolidated)
`
` Neptune Generics, LLC v. Eli Lilly & Co., Patent Trial and Appeal
`
`Board, IPR2016-00237
`
` Neptune Generics, LLC v. Eli Lilly & Co., Patent Trial and Appeal
`
`Board, IPR2016-00240
`
` Sandoz Inc. v. Eli Lilly & Co., Patent Trial and Appeal Board,
`
`IPR2016-00318
`
` Eli Lilly & Co. v. Dr. Reddy’s Laboratories Ltd., et al., S.D. Indiana
`
`Case No. 1:16-cv-00308-TWP-DKL
`
` Eli Lilly & Co. v. Biocon Limited, S.D. Indiana Case No. 1:16-cv-
`
`00469-TWP-DKL
`
` Apotex Inc. & Apotex Corp. v. Eli Lilly & Company, Patent Trial and
`
`Appeal Board, IPR2016-01190
`
` Apotex Inc. & Apotex Corp. v. Eli Lilly & Company, Patent Trial and
`
`Appeal Board, IPR2016-01191
`
` Wockhardt Bio AG v. Eli Lilly & Company, Patent Trial and Appeal
`
`Board, IPR2016-01335
`
` Wockhardt Bio AG v. Eli Lilly & Company, Patent Trial and Appeal
`
`Board, IPR2016-01337
`
`3
`
`
`
`
`
`Case IPR 2016-01393
`Patent 7,772,209
` Teva Pharmaceuticals USA, Inc. & Fresenius Kabi USA, LLC v. Eli
`
`Lilly & Company, Patent Trial and Appeal Board, IPR2016-01340
`
` Teva Pharmaceuticals USA, Inc. & Fresenius Kabi USA, LLC v. Eli
`
`Lilly & Company, Patent Trial and Appeal Board, IPR2016-01341
`
` Teva Pharmaceuticals USA, Inc. & Fresenius Kabi USA, LLC v. Eli
`
`Lilly & Company, Patent Trial and Appeal Board, IPR2016-01343
`
` Apotex Inc., Apotex Corp., Emcure Pharmaceuticals Ltd., Heritage
`
`Pharma Labs Inc., Heritage Pharmaceuticals Inc., Glenmark
`
`Pharmaceuticals Inc., USA, Glenmark Holding SA, Glenmark
`
`Pharmaceuticals Ltd., Mylan Laboratories Limited, Patent Trial and
`
`Appeal Board, IPR2016-01429
`
`C. Lead and Back-Up Counsel (37 C.F.R. § 42.8(b)(3))
`Patent Owner designates the following counsel:
`
`Lead Counsel:
`
`
`
`Dov P. Grossman (Reg. No. 72,525)
`Williams & Connolly LLP
`
`725 Twelfth St. NW
`Washington DC 20005
`Direct Phone: 202-434-5812
`Facsimile: 202-434-5029
`
`David M. Krinsky (Reg. No. 72,339)
`Williams & Connolly LLP
`
`725 Twelfth St. NW
`Washington DC 20005
`Direct Phone: 202-434-5338
`Facsimile: 202-480-8302
`
`4
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Back-up Counsel:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR 2016-01393
`Patent 7,772,209
`James P. Leeds (Reg. No. 35,241)
`Eli Lilly and Company
`Lilly Corporate Center
`Indianapolis, IN 46285
`Direct Phone: 317-276-1667
`Facsimile: 317-277-6534
`
`Back-up Counsel:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`D.
`Please direct all correspondence regarding this proceeding to the lead
`
`Service Information (37 C.F.R. § 42.8(b)(4))
`
`counsel at the address listed above. Patent Owner also consents to electronic
`
`service by email to dgrossman@wc.com, dkrinsky@wc.com, and
`
`leeds_james@lilly.com.
`
`
`
`The Patent Trial and Appeal Board is hereby authorized to charge any fees
`
`associated with this proceeding to Deposit Account 506403.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Dov P. Grossman/
`Dov P. Grossman
`Reg. No. 72,525
`Lead Counsel for
`Patent Owner
`
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, D.C. 20005
`202-434-5812 (Telephone)
`202-434-5029 (Facsimile)
`dgrossman@wc.com
`
`
`
`Date: July 19, 2016
`
`
`
`
`
`
`
`
`
`
`
`5
`
`
`
`Case IPR 2016-01393
`Patent 7,772,209
`
`CERTIFICATE OF SERVICE
`(37 C.F.R. § 42.6(e))
`
`The undersigned hereby certifies that the foregoing Patent Owner Eli Lilly &
`
`
`
`Company’s Mandatory Notices Under 37 C.F.R. § 42.8(a)(2) was served on July
`
`19, 2016 by delivering a copy via electronic mail on the following attorneys of
`
`record for the Petitioner:
`
`Patrick A. Doody
`Reg. No. 35,022
`P: 703-770-7755
`patrick.doody@pillsburylaw.com
`
`Bryan P. Collins
`Reg. No. 43,560
`P: 703-770-7538
`bryan.collins@pillsburylaw.com
`
`Pillsbury Winthrop Shaw Pittman LLP
`1650 Tysons Boulevard
`McLean, VA 22102
`F: 312-527-4205
`
`
`
`
`
`/Dov P. Grossman/
`Dov P. Grossman
`Reg. No. 72,525
`Lead Counsel for Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Date: July 19, 2016